These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 29726090)

  • 1. Gene expression signatures prognostic for relapse in stage I testicular germ cell tumours.
    Lewin J; Soltan Ghoraie L; Bedard PL; Hamilton RJ; Chung P; Moore M; Jewett MAS; Anson-Cartwright L; Virtanen C; Winegarden N; Tsao J; Warde P; Sweet J; Haibe-Kains B; Hansen AR
    BJU Int; 2018 Nov; 122(5):814-822. PubMed ID: 29726090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Lactate Dehydrogenase in Identifying Relapse for Patients With Stage I Testicular Cancer on Surveillance.
    Bobrowski A; Anson-Cartwright L; Kuhathaas K; Jiang DM; Chung P; Bedard P; Warde P; O'Malley M; Sweet J; Hamilton RJ
    J Urol; 2022 Dec; 208(6):1250-1258. PubMed ID: 35997696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression microarray analysis of adult testicular germ cell tumor: a comparison between pure-type seminomas and seminoma components in mixed tumors.
    Miyai K; Yonekura Y; Ito K; Matsukuma S; Tsuda H
    Virchows Arch; 2021 Dec; 479(6):1177-1186. PubMed ID: 34347114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metastatic potential of seminomatous germ cell tumours is associated with a specific microRNA pattern.
    Ernst S; Heinzelmann J; Bohle RM; Weber G; Stöckle M; Junker K; Heinzelbecker J
    Andrology; 2020 Nov; 8(6):1687-1698. PubMed ID: 32530514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of lactate dehydrogenase in the follow-up of testicular germ cell tumours.
    Venkitaraman R; Johnson B; Huddart RA; Parker CC; Horwich A; Dearnaley DP
    BJU Int; 2007 Jul; 100(1):30-2. PubMed ID: 17552950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic Characterization of Bilateral Testicular Germ Cell Tumors With Immunohistochemical Evaluation of Mismatch Repair and
    Al-Obaidy KI; Trevino KE; Idrees MT
    Int J Surg Pathol; 2019 Sep; 27(6):619-623. PubMed ID: 30983459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNAs and Biomarkers in Testicular Germ Cell Tumors: An Update.
    De Martino M; Chieffi P; Esposito F
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary mediastinal germ cell tumours with high prevalence of somatic malignancy: An experience from a single tertiary care oncology centre.
    Beg A; Kumar R; Sahay A; Janu A; Joshi A; Noronha V; Prabhash K; Karimundackal G; Jiwnani S; Agarwal JP; Pramesh CS
    Ann Diagn Pathol; 2021 Aug; 53():151763. PubMed ID: 34111707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).
    Rothermundt C; Thurneysen C; Cathomas R; Müller B; Mingrone W; Hirschi-Blickenstorfer A; Wehrhahn T; Ruf C; Rothschild S; Seifert B; Terbuch A; Grassmugg T; Woelky R; Fankhauser C; Kunit T; Fischer N; Inauen R; Kamradt J; Ziegler K; Haynes A; Jüni P; Gillessen S
    Swiss Med Wkly; 2018; 148():w14640. PubMed ID: 30044478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.
    Lago-Hernandez CA; Feldman H; O'Donnell E; Mahal BA; Perez V; Howard S; Rosenthal M; Cheng SC; Nguyen PL; Beard C; D'Amico AV; Sweeney CJ
    Ann Oncol; 2015 Jul; 26(7):1396-401. PubMed ID: 25888612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testicular Germ-Cell Tumours: A Descriptive Analysis of Clinical Characteristics at First Presentation.
    Dieckmann KP; Richter-Simonsen H; Kulejewski M; Ikogho R; Zecha H; Anheuser P; Pichlmeier U; Isbarn H
    Urol Int; 2018; 100(4):409-419. PubMed ID: 29649815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
    Terbuch A; Adiprasito JB; Stiegelbauer V; Seles M; Klec C; Pichler GP; Resel M; Posch F; Lembeck AL; Stöger H; Szkandera J; Pummer K; Bauernhofer T; Hutterer GC; Gerger A; Stotz M; Pichler M
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30321995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma.
    Hosni A; Warde P; Jewett M; Bedard P; Hamilton R; Moore M; Nayan M; Huang R; Atenafu EG; O'Malley M; Sweet J; Chung P
    Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):648-54. PubMed ID: 27339401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathological and molecular features of late relapses in non-seminomas.
    Mayer F; Wermann H; Albers P; Stoop H; Gillis AJ; Hartmann JT; Bokemeyer CC; Oosterhuis JW; Looijenga LH; Honecker F
    BJU Int; 2011 Mar; 107(6):936-43. PubMed ID: 20955261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
    Kawai T; Tanaka Y;
    Int J Urol; 2017 Feb; 24(2):124-128. PubMed ID: 27915468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours.
    Almstrup K; Lobo J; Mørup N; Belge G; Rajpert-De Meyts E; Looijenga LHJ; Dieckmann KP
    Nat Rev Urol; 2020 Apr; 17(4):201-213. PubMed ID: 32157202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current knowledge of risk factors for testicular germ cell tumors.
    Fukawa T; Kanayama HO
    Int J Urol; 2018 Apr; 25(4):337-344. PubMed ID: 29345008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDX2 immunostaining in primary and metastatic germ cell tumours of the testis.
    Oz Atalay F; Aytac Vuruskan B; Vuruskan H
    J Int Med Res; 2016 Dec; 44(6):1323-1330. PubMed ID: 28322096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of relapse in stage I testicular germ cell tumor patients on surveillance: investigation of biomarkers.
    Lobo J; Gillis AJM; van den Berg A; Looijenga LHJ
    BMC Cancer; 2020 Aug; 20(1):728. PubMed ID: 32758242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours.
    Sanmamed MF; Esteban E; Uriol E; Zarate R; Capelan M; Muriel C; Crespo G; Berros JP; Pardo-Coto P; Perez Q; Alvarez-Fernández C; Jiménez Fonseca P; Luque M; Astudillo A
    J Transl Med; 2017 Mar; 15(1):62. PubMed ID: 28320414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.